Kursat Ozdilli
Overview
Explore the profile of Kursat Ozdilli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
174
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oguz S, Kivanc D, Ozdilli K, Karadeniz S, Gurer Kluge E, Senturk Ciftci H
Iran J Kidney Dis
. 2025 Mar;
19(1):59-66.
PMID: 40056445
Introduction: Activation of the complement system following transplantation may result in allograft rejection. Our study aimed to evaluate the potential relationship between factors affecting kidney transplant success and complement 5...
2.
Bayram N, Yaman Y, Ozdilli K, Nepesov S, Al I, Elli M, et al.
J Pediatr Hematol Oncol
. 2024 Dec;
47(1):e10-e14.
PMID: 39737632
Introduction: Thrombocytopenia is a common clinical problem in cancer patients undergoing high-dose chemotherapy and autologous hematopoietic stem cell transplantation (HSCT). It can occur as prolonged isolated thrombocytopenia (PIT) or secondary...
3.
Ozdilli K, Mervan Aytac H, Tuncel F, Oyaci Y, Pehlivan M, Pehlivan S
Neurosciences (Riyadh)
. 2024 Jan;
29(1):51-56.
PMID: 38195135
Objectives: To evaluate the genetic polymorphisms in and genes in schizophrenia (SCZ) patients by comparing them with healthy controls. Methods: A sample of 127 patients with SCZ and 100 healthy...
4.
Oguz R, Senturk Ciftci H, Gokce M, Ogret Y, Karadeniz S, Pehlivan S, et al.
Hematol Transfus Cell Ther
. 2023 Apr;
46(4):327-334.
PMID: 37117150
Introduction: Epidemiologic studies on pediatric acute lymphoblastic leukemias (ALL) have been conducted to evaluate the possible risk factors including genetic, infectious and environmental factors with the objective of idenfying the...
5.
Nepesov S, Yaman Y, Elli M, Bayram N, Ozdilli K, Kiykim A, et al.
Turk Arch Pediatr
. 2022 Jul;
57(4):398-405.
PMID: 35822471
Objective: In this study, we sought to describe the clinical, laboratory, and genetic character- istics of patients diagnosed with primary hemophagocytic lymphohistiocytosis. Thus, we aimed to evaluate the early diagnosis...
6.
Nepesov S, Yaman Y, Elli M, Bayram N, Ozdilli K, Ayaz A, et al.
Indian J Pediatr
. 2022 Mar;
89(9):894-898.
PMID: 35267133
Objectives: To describe the clinical characteristics of patients with chronic neutropenia. Methods: Data of 36 patients with chronic neutropenia, who were followed up in the authors' clinic between May 2013...
7.
Bayram N, Yaman Y, Elli M, Ozdilli K, Nepesov S, Dogan M, et al.
Pediatr Transplant
. 2022 Feb;
26(4):e14255.
PMID: 35187769
Background: PNPK gene mutations result in DNA repair disorders and have a spectrum of neurodevelopmental manifestations. To date, cancer predisposition has not been described in patients with PNKP mutations. Observation:...
8.
Bayram N, Yaman Y, Ozdilli K, Telhan L, Nepesov S, Bilgen H, et al.
Pediatr Transplant
. 2021 Apr;
25(4):e14024.
PMID: 33860589
Introduction: (Ph-like) ALL is a subset of leukemia which has a gene expression profile similar to Ph+disease, but without the presence of BCR-ABL1 translocation. Case Description: We reported an exceptional...
9.
Ozdilli K, Pehlivan M, Serin I, Savran F, Tomatir A, Pehlivan S
Mediterr J Hematol Infect Dis
. 2021 Mar;
13(1):e2021020.
PMID: 33747401
No abstract available.
10.
Yaman Y, Elli M, Sahin S, Ozdilli K, Bilgen H, Bayram N, et al.
Pediatr Transplant
. 2021 Jan;
25(5):e13962.
PMID: 33452850
Delayed recovery of thrombocytopenia is a well-known complication after allogeneic HSCT. Eltrombopag (ELT), a thrombopoietin receptor agonist (TRAs), induces platelet maturation and release. Mostly conducted in adults, some of the...